Showing results (1331-1340 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|December 7, 2023
Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate CancerAnouk C de Jong, Khrystany T Isebia, Sui Wai Ling, et al.
JCO Precision Oncology|January 5, 2024
Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future ProspectsZhulin Yin, Adrian P Mander, Johann S de Bono, et al.
JCO Precision Oncology|January 2, 2024
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer CarePhillip G Febbo, Mina Allo, Emma B Alme, et al.
JCO Precision Oncology|December 1, 2023
Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA PopulationMicaela R Scobie, Katherine I Zhou, Sara Ahmed, et al.
JCO Precision Oncology|February 8, 2024
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint InhibitorsCsaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, et al.
JCO Precision Oncology|February 8, 2024
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung CancerAbdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, et al.
JCO Precision Oncology|January 31, 2024
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional StudyMegan L Hutchcraft, Shulin Zhang, Nan Lin, et al.
JCO Precision Oncology|January 11, 2024
Somatic Versus Germline: A Case Series of Three Children With ATM-Mutated MedulloblastomaLydia T Tam, Bonnie Cole, Shannon M Stasi, et al.
JCO Precision Oncology|January 8, 2024
Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology TrialsDerrick H W Siu, Frank P Y Lin, Doah Cho, et al.
JCO Precision Oncology|March 21, 2024
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung CancerPetros Christopoulos, Michal Harel, Kimberly McGregor, et al.
Pageof 140